A second Danone division is the subject of bribery allegations in China.

Nutricia, Danone’s medical nutrition arm, is alleged to have paid over 100 doctors in Beijing to boost sales.

Nutricia, which produces Karicare milk formula is said to have bribed doctors at 14 hospitals with between 2010 and 2013, the 21st Century Business Herald said yesterday (26 September), citing an anonymous source who claimed to be a student doctor. The bribes included gifts and tickets to shows, the paper said.

The allegations are the second set to hit Danone in the space of a week. Last week, Danone’s baby food arm in China, Dumex, was accused of paying medical staff at a hospital in Tianjin to promote products to the parents of newborn children.

Danone said then it would launch an investigation into the Dumex allegations and, in a statement, Nutricia said it would do the same into the new claims.

“Nutricia China pays serious attention to the recent media coverage, and has immediately launched an internal investigation,” it told just-food.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This summer, local employees of UK pharmaceutical giant GlaxoSmithKline were arrested for allegedly bribing doctors and officials to secure higher prices and win sales. This week, analysts at Citi said GSK‘s sales in China had dropped 30% since the scandal as hospitals refused entry to the company’s sales reps.